Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?
- 1 January 2009
- journal article
- cancer
- Published by Wolters Kluwer Health in Current Opinion in HIV and AIDS
- Vol. 4 (1) , 42-51
Abstract
Purpose of review There is an increasing burden of non-AIDS-defining malignancies (NADMs) in the antiretroviral therapy (ART) era. The recent literature is reviewed with respect to NADM risk, ART use, and immune function. Recent findings Recent studies have increasingly focused on individual ART use, CD4 T-cell counts, and the risk of NADMs. Certain NADMs have been shown to have a reduced risk with ART use including liver, breast, colorectal, and lung cancers. NADMs associated with immunosuppression included Hodgkin's lymphoma, oral/pharynx, lung, anal, and colorectal cancers. Despite the potential protective effect of ART on some NADMs, recent studies evaluating calendar era trends have noted an increased risk of Hodgkin's lymphoma and anal cancer and no change in risk for lung cancer in the ART era. Summary Successful ART use and improvements in immune function for HIV-infected persons may reduce the risk of certain NADMs. However, a continued high risk in the ART era for certain cancers have been observed, including Hodgkin's lymphoma and anal cancers. Future studies should monitor trends in NADMs in HIV-infected persons in the ART era, as well as changes in the prevalence of risk factors, coinfections, and screening practices in this population.Keywords
This publication has 62 references indexed in Scilit:
- Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV‐1–Infected, Treatment‐Experienced Patients: AIDS Clinical Trials Group 5211The Journal of Infectious Diseases, 2007
- Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysisThe Lancet, 2007
- Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)Leukemia & Lymphoma, 2005
- AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral TherapyJAMA, 1999
- Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi‚s sarcomaAIDS, 1999
- Risk of cancer in people with AIDSAIDS, 1999
- Spectrum of AIDS-associated malignant disordersThe Lancet, 1998
- Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposiʼs sarcomaAIDS, 1998
- Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.1997
- Reduction of Kaposiʼs sarcoma lesions following treatment of AIDS with ritonovirAIDS, 1997